(Q77476564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

blood-cerebrospinal fluid barrier

1 reference

M J Schwarz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Ackenheil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Riedel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

N Müller

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

201-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

Blood-cerebrospinal fluid barrier in schizophrenic patients

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Junctions between intimately apposed cell membranes in the vertebrate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Abnormal cerebrospinal fluid protein indices in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Pathophysiology of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900655-7

7 January 2021

10.1016/S0304-3940(98)00655-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9792246%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference